Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Mar 30, 2017 · 10-K · 89 days after period end · 0001193125-17-102052
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|
| Revenue | $2.73M | $2.14M | — |
| Net Income | -$6.56M | -$2.90M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 30, 2017 · 89 d after period end
